Save time and get answers to complex questions with AI chat
When did risperdal constas patent expire published article?When will a generic version of xiaflex be available?Guselkumab brand name?Allergan's patent for latisse expired?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Propylthiouracil
Propylthiouracil (PTU) treats hyperthyroidism by lowering thyroid hormone production. It does this in two main ways: it blocks thyroid hormone synthesis and it reduces the conversion of T4 (thyroxine) into the more active T3 (triiodothyronine). [1]
PTU inhibits thyroid peroxidase (TPO), the enzyme needed for key steps in making thyroid hormones inside the thyroid gland. By inhibiting TPO, PTU reduces the formation of T3 and T4, which lowers circulating thyroid hormone levels. [1]
Beyond blocking synthesis, PTU also inhibits an enzyme involved in converting T4 to T3 in peripheral tissues (outside the thyroid), which further decreases active T3 levels. This contributes to a faster drop in thyroid hormone activity compared with drugs that only block synthesis. [1]
Because PTU reduces both hormone production (via TPO inhibition) and peripheral activation (T4 to T3 conversion), it can rapidly improve the biochemical and clinical picture of hyperthyroidism while the underlying thyroid overactivity is controlled. [1]
[1] https://en.wikipedia.org/wiki/Propylthiouracil
Other Questions About Propylthiouracil :